Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors

Journal of Cellular Biochemistry

Volumn 92, Issue 3, 2004, Pages 491-501

  Aprelikova, Olga ^a   Chandramouli, Gadisetti V R ^a   Wood, Matthew ^a   Vasselli, James R ^a   Riss, Joseph ^a   Maranchie, Jodi K ^a,b   Linehan, W Marston ^a   Barrett, J Carl ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

HIF; Hypoxia; Microarray; Prolyl hydroxylases; siRNA

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; VON HIPPEL LINDAU PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DIOXYGENASE; DNA BINDING PROTEIN; EGLN1 PROTEIN, HUMAN; EGLN3 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 2, ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR 2, ALPHA SUBUNIT; IMMEDIATE EARLY PROTEIN; MESSENGER RNA; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; VHL PROTEIN, HUMAN;

ARTICLE; DOWN REGULATION; GENE CONTROL; GENE INDUCTION; HYPOXIA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; CELL HYPOXIA; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MUTATION; RNA INTERFERENCE; TUMOR CELL LINE;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; CELL LINE, TUMOR; DIOXYGENASES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMEDIATE-EARLY PROTEINS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROCOLLAGEN-PROLINE DIOXYGENASE; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 4644237401     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20067     Document Type: Article

References (42)

1. Andrews NC, Faller DV. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
2. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. 2003. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J 22:4082-4090.
3. Brown JM, Giaccia AJ. 1998. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58:1408-1416.
4. Bruick RK. 2003. Oxygen sensing in the hypoxic response pathway: Regulation of the hypoxia-inducible transcription factor. Genes Dev 17:2614-2623.
5. Bruick RK, McKnight SL. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337-1340.
6. Chan DA, Sutphin PD, Denko NC, Giaccia AJ. 2002. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1 alpha. J Biol Chem 277:40112-40117.
7. Cioffi CL, Liu XQ, Kosinski PA, Garay M, Bowen BR. 2003. Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem Biophys Res Commun 303:947-953.
8. Damert A, Ikeda E, Risau W. 1997. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells. Biochem J 327:419-423.
9. del Peso L, Castellanos MC, Temes E, Martin-Puig S, Cuevas Y, Olmos G, Landazuri MO. 2003. The von Hippel Lindau/Hypoxia inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase to low oxygen. J Biol Chem 278:48690-48695.
10. Ebert BL, Bunn HF. 1998. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Mol Cell Biol 18:4089-4096.
11. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson M, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, Ratcliffe PJ. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54.
12. Goonewardene TI, Sowter HM, Harris A. 2002. Hypoxia-induced pathways in breast cancer. Microscopy Res Tech 59:41-48.
13. Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, Myllyharju J. 2003. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278:30772-30780.
14. Hockel M, Schlenger K, Mitze M, Schaffer U, Vaupel P. 1996. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 6:3-9.
15. Huang LE, Bunn HF. 2003. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem 278:19575-19578.
16. Huang LE, Arany Z, Livingston DM, Bunn HF. 1996. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271:32253-32259.
17. Huang LE, Gu J, Schau M, Bunn HF. 1998. Regulation of hypoxia-inducible factor 1alpha is mediated by an U2-dependent degradation domain via the ubuquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987-7992.
18. Huang J, Zhao Q, Mooney SM, Lee FS. 2002. Sequence determinants in hypoxia-inducible factor-1 alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2 and PHD3. J Biol Chem 277:39792-39800.
19. Isaacs JS, Yung YJ, Mimnaugh EG, Martinez A, Cuttitta F, Neckers LM. 2002. Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway. J Biol Chem 277:29936-29944.
20. 2 sensing. Science 292:464-468.
21. Ivan M, Haberberger T, Gervasi DC, Mickelson KS, Gunzler V, Kondo K, Yang H, Sorokina I, Canaway RC, Conaway JW, Kaelin WJ, Jr. 2002. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA 99:13459-13464.
22. 2-regulated prolyl hydroxylation. Science 292:468-472.
23. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H. 2000. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95:189-197.
24. Laderoute KR, Calaoagan JM, Gustafson-Brown C, Knapp AM, Li G-C, Mendonca HL, Ryan HE, Wang Z, Johnson RS. 2002. The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol Cell Biol 22:2515-2023.
25. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. 2002a. Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch. Science 295:858-861.
26. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. 2002b. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16:1466-1471.
27. Lieb ME, Menzies K, Moschella MC, Ni R, Taubman MB. 2002. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem Cell Biol 80:421-426.
28. Mahon PC, Hirota K, Semenza GL. 2001. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15:2675-2686.
29. Maranchie JK, Vasselli JR, Riss J, Bonifacino JS, Linehan WM, Klausner RD. 2002. The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell 1:247-255.
30. Maxwell PH, Pugh CW, Ratcliffe PJ. 1993. Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: Evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci USA 90:2423-2427.
31. Metzen E, Berchner-pfannschmidt U, Stengel P, Marxsen JH, Stolze I, Kalinger M, Huang QW, Wotzlaw C, Hellwig-Burgel T, Jelkmann W, Acker H, Fandrey J. 2003. Intracellular localisation of human HIF-1 alpha hydroxylases: Implications for oxygen sensing. J Cell Sci 116:1319-1326.
32. Nagao M, Ebert BL, Ratcliffe PJ, Pugh CW. 1996. Drosophila melanogaster SL2 cells contain a hypoxically inducible DNA binding complex which recognises mammalian HIF-binding sites. FEBS Lett 387:161-166.
33. 2-responsive sequences on the tyrosine hydroxylase gene. J Biol Chem 270:23774-23779.
34. Ravi R, Mookerjee B, Bhujwalla ZJM, Satter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL, Bedi A. 2000. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev 14:34-44.
35. Rossi FMV, Guicherit OM, Spicher A, Kringstein AM, Fatyol K, Blakely BT, Blau H. 1998. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nat Genet 20:389-393.
36. 2 homeostasis by hypoxia-inducible factor 1. Rev Cell Dev Biol 15:551-578.
37. Semenza GL. 2003. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 10:721-732.
38. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE. 1991. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA 88:5680-5684.
39. 2-regulated gene expression. FASEB J 16:1151-1162.
40. Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ. 2000. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 19:6297-6305.
41. Yu F, White SB, Zhao Q, Lee FS. 2001. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 98:9630-9635.
42. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. 1999. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59:5830-5835.